Catherine J. Wu: Personalizing medicine through cancer vaccines

Personal Cancer Vaccines: Customized Treatment for Each PatientПодробнее

Addressing Cancer Clonal Heterogeneity: Developing Personalized Neoantigen-Based Cancer VaccinesПодробнее

Catherine J. Wu, M.D., Dana-Farber Cancer Institute, Chronic Lymphocytic LeukemiaПодробнее

2023 Koch Institute Symposium - Cancer Vaccines: Session 2, Panel DiscussionПодробнее

Catherine Wu, MD - CLL Research | Dana-Farber Cancer InstituteПодробнее

SU2C IRG Profile: Dr. Catherine WuПодробнее

CGC 2022 Keynote Presentation - Using Genomics to Build Better Cancer VaccinesПодробнее

Addressing Cancer Clonal Heterogeneity: Developing Personalized Neoantigen-Based Cancer VaccinesПодробнее

CLL at a genomic levelПодробнее

Personalized Cancer Vaccines and Cellular Therapy in Solid TumorsПодробнее

Gene Therapies and Cancer VaccinesПодробнее

Personalized cancer vaccine helps patientПодробнее

The future of CLL treatment: chemotherapy and targeted inhibitorsПодробнее

Cancer and VaccinesПодробнее

Therapeutic Cancer Vaccines – The Way Forward?Подробнее

KCRS21: Immunotherapy Advances and ResearchПодробнее

She is awarded the Sjöberg Prize for laying the foundations of a cancer vaccineПодробнее

Enhancing personalized therapeutic cancer vaccine developmentПодробнее

A Turning Point for Cancer VaccinesПодробнее